SCHEMBL23359802

SCHEMBL23359802

CC(=O)Nc1ccc(NC2CCN(C(=O)OC(C)(C)C)CC2)c2cccnc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
EPHX2 P34913 1/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GPR119 Q8TDV5 5/20 0.47
CCR8 P51685 1/20 0.47
POLB P06746 1/20 0.45
JAK1 P23458 1/20 0.45
USP30 Q70CQ3 2/20 0.44
DTYMK P23919 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CNR1 P21554 1/20 0.43
NOS2 P35228 1/20 0.43
TGFBR1 P36897 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28834053 0.94 USP30 (0.49) EPHX2GPR119CCR8USP30CNR1
SCHEMBL28834051 0.94 USP30 (0.49) EPHX2GPR119CCR8USP30CNR1
SCHEMBL29862411 0.94 USP30 (0.49) EPHX2GPR119CCR8USP30CNR1
SCHEMBL23359862 0.88 ALDH1A1 (0.49) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23359875 0.87 GPR119 (0.51) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23360027 0.86 ALDH1A1 (0.47) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23360605 0.85 CCR8 (0.46) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23359653 0.85 EPHX2 (0.54) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23360492 0.85 ALDH1A1 (0.46) ALDH1A1EPHX2NPC1MAPTMAPK1
SCHEMBL23360388 0.84 EPHX2 (0.49) ALDH1A1EPHX2NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL ALDH1A1 439/4885EPHX2 2516/4885NPC1 2057/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL ALDH1A1 439/4885EPHX2 2516/4885NPC1 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.